newdrugapprovals.org
AstraZeneca’s Forxiga receives positive advice from Scottish Medicines Consortium
DAPAGLIFLOZIN SYNTHESIS AstraZeneca announced that the Scottish Medicines Consortium (SMC) has issued positive advice for use of its Forxiga, a selective and reversible inhibitor of sodium-gl…